Flow Cytometric Profiling Reveals Platelet Dysfunction and Impaired Immune Communication in Acute and Chronic Cerebrovascular Disease
Open Access
- 9 March 2026
- journal article
- Published by Wiley in Journal of Clinical Laboratory Analysis
- Vol. 40 (7) , e70192
Abstract
Introduction: Beyond hemostasis and thrombosis, platelets are increasingly recognized as multifunctional cells involved in inflammation, vascular remodeling, and neurological diseases. Chronic cerebrovascular diseases impair cerebral blood flow and oxygen supply, leading to cognitive and motor dysfunction, where platelets may act as peripheral sensors reflecting neurovascular stress. This study investigated platelet activation profiles and platelet–leukocyte interactions in acute intracerebral hemorrhage (aICH), subacute intracerebral hemorrhage (sICH), and chronic cerebrovascular diseases (CCD). Methods: Flow cytometry was used to assess platelet functions, including PAC‐1 (activated GPIIb/IIIa) and P‐selectin (CD62P), and platelet–leukocyte aggregates, including myeloid‐platelet, lymphocyte‐platelet, and monocyte‐platelet in 20 CCD, 20 aICH, 30 sICH patients, and 48 healthy controls. Results: PAC‐1 expression was significantly reduced in aICH and sICH but elevated in CCD, indicating impaired integrin activation in acute and subacute stages and compensatory hyperreactivity in chronic disease. P‐selectin expression was markedly decreased in CCD under both ADP and TRAP stimulation, suggesting persistent α‐granule dysfunction in chronic conditions. Lymphocyte–platelet aggregates, especially T‐cell interactions, were consistently diminished across all patient groups, reflecting disturbed platelet–immune communication with T lymphocytes. Conclusion: Patients with cerebrovascular disorders show distinct platelet activation patterns and impaired immune crosstalk. Reduced P‐selectin expression and decreased lymphocyte–platelet aggregation, especially T‐cell, indicate sustained platelet dysfunction and disrupted neuroinflammatory regulation. Flow cytometric assessment of these parameters provides valuable insight into neurovascular diseases at different stages and potential biomarkers for disease monitoring.Keywords
Funding Information
- Buddhist Tzu Chi Medical Foundation (TCMMP112‐01‐03)
- Buddhist Tzu Chi Medical Foundation (TCMF‐EP 110‐02)
- Buddhist Tzu Chi Medical Foundation (TCMF‐MP 113‐01‐02)
- Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation (TCMF‐CM2‐112‐05)
This publication has 42 references indexed in Scilit:
- When the victim becomes the villain: Platelets as drivers of immune dysregulation in ITPJournal of Translational Autoimmunity, 2025
- Immunophenotypic Analysis of Platelets by Flow CytometryCurrent Protocols, 2021
- Platelets: The missing link between the blood and brain?Progress in Neurobiology, 2019
- Platelet CD40L induces activation of astrocytes and microglia in hypertensionBrain, Behavior, and Immunity, 2017
- Whole Blood Analysis of Leukocyte‐Platelet AggregatesCurrent Protocols in Cytometry, 2016
- Human platelet lysate: Replacing fetal bovine serum as a gold standard for human cell propagation?Biomaterials, 2016
- CD62-mediated activation of platelets in cerebral white matter lesions in patients with cognitive declineArchives of Gerontology and Geriatrics, 2016
- Predictive Value of High Residual Platelet Reactivity by Flow Cytometry for Outcomes of Ischemic Stroke Patients on Clopidogrel TherapyJournal of Stroke and Cerebrovascular Diseases, 2015
- Mitochondrial dysfunction in schizophrenia: Pathways, mechanisms and implicationsNeuroscience & Biobehavioral Reviews, 2015
- Methods for the Measurement of Platelet FunctionThe American Journal of Cardiology, 2009